Balyasny Asset Management’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,763
Closed -$651K 2264
2018
Q2
$651K Sell
4,763
-13,621
-74% -$1.24M ﹤0.01% 1262
2018
Q1
$1.45M Buy
+18,384
New +$1.36M 0.01% 1091

Balyasny Asset Management's FMI Position: Q3 2018 in Review

Balyasny Asset Management sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 4,763 shares — an estimated $651K sold.

Balyasny Asset Management first reported a position in FMI in Q1 2018 and held it in 2 quarters. The position peaked at $1.45M in Q1 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Balyasny Asset Management reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 4,763 Foundation Medicine, Inc. shares in Q3 2018, an estimated $651K.
  • Balyasny Asset Management first reported a position in Foundation Medicine, Inc. in Q1 2018 and held it in 2 quarters.
  • Balyasny Asset Management's Foundation Medicine, Inc. position peaked at $1.45M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.